Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuwellis Inc (NQ: NUWE )

0.2572 +0.0862 (+50.41%)
Streaming Delayed Price Updated: 11:12 AM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nuwellis Inc

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END 
Via FinancialNewsMedia
Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG Patients
Nuwellis, Inc. (NASDAQ: NUWE) is engaged as a medical device company, which is focused on the development and commercialization of 
Via Spotlight Growth
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.